• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GERN:US

2.5850 USD 0.0050 0.19%

As of 12:01:38 ET on 07/23/2014.

Company Profile for Geron Corp (GERN)

Geron Corporation is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

Contact Information

Geron Corp

230 Consititution Drive
Menlo Park, CA 94025
United States
Phone: 1-650-473-7700
Fax: 1-650-473-7750

Key Executives for Geron Corp (GERN)

John A ScarlettPresident/CEOOlivia K BloomExec VP:Finance/CFO/Treasurer
Stephen N RosenfieldExec VP/General Counsel/SecyAndrew J Grethlein "Andy"Exec VP:Tech Operations
Melissa A Kelly BehrsExec VP:Portfolio MgmtCraig C ParkerExec VP:Corp Development
Anna KrassowskaInvestor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil